ClinicalTrials.gg
Drug

Linvoseltamab clinical trials

Also written REGN5458 and Lynozyfic™.

studies test it
19
open now
15
in phase 3
6
first study started
2019

How each study uses linvoseltamab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the linvoseltamab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
2 Jul 2025 · LYNOZYFIC · BLA 761400 (FDA, Drugs@FDA)
European Union
23 Apr 2025 · Lynozyfic · EMEA/H/C/006370 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Linvoseltamab
19

Brand

Lynozyfic™
12

Development codes

REGN5458
15

Studies by the year they started

19 studies that test it; most in 2026 (8)

Studies that test linvoseltamab, by start year
YearStudies
20191
20232
20246
20252
20268

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
12
Phase 3
6
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 6

Regeneron Pharmaceuticals (13) · Dickran Kazandjian, MD (2) · Medical College of Wisconsin (1) · Multiple Myeloma Research Consortium (1) · Fred Hutchinson Cancer Center (1) · European Myeloma Network B.V. (1)

Often tested with

Tested in the same studies.

Carfilzomib (1) · Tocilizumab (1) · REGN7945 (1) · Lenalidomide (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test linvoseltamab.

Studies

Open first, then newest update. How each study uses linvoseltamab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 19

Given beside what is tested · 3 — linvoseltamab is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with linvoseltamab

Codes

What other systems call linvoseltamab · ClinicalTrials.gg INT002143

  • MeSH (NLM) C000731817linvoseltamabOne source NLM
  • UNII (FDA) M3CPC50MZSLINVOSELTAMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q133445837linvoseltamabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C158504LinvoseltamabOne source FDA
  • DrugBank DB17447One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.